SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Apr 16, 2021
Document Date
Apr 16, 2021
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Verve Therapeutics
Issuer
VERVE THERAPEUTICS, INC.